XML 43 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Other Intangible Assets
12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets GOODWILL AND OTHER INTANGIBLE ASSETS
We performed our annual impairment test for goodwill as of October 31, 2022 and determined that the carrying value of the Spine reporting unit exceeded its fair value. As a result an impairment charge of $216 was recognized in the Goodwill impairment line in the Consolidated Statements of Earnings in 2022. As of December 31, 2022 goodwill of the Spine reporting unit is $1,002 after the impairment charge.
We estimated the fair value of the Spine reporting unit using a discounted cash flow analysis. Significant inputs to the analysis include assumptions for future revenue growth and operating margin. The analysis also included a rate to discount the estimated future cash flow projections to their present value, based on the reporting unit’s estimated weighted average cost of capital. The impairment charge for the Spine reporting unit was primarily driven by the slower than anticipated recovery of surgery volumes as we emerge from the COVID-19 pandemic, the competitive pressures in the spine market and rising interest rates in the current macroeconomic environment.
For our other reporting units, we considered qualitative indicators of impairment as it was considered more likely than not that the fair values of those reporting units exceeded their respective carrying values. No impairment was identified for those reporting units in 2022.
Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill, including discount and tax rates and future cash flow projections, could result in significantly different estimates of the fair values. A significant reduction in the estimated fair values could result in impairment charges that could materially affect our results of operations.
Changes in the Net Carrying Value of Goodwill by Segment
MedSurg and NeurotechnologyOrthopaedics and SpineTotal
2020$5,459 $7,319 $12,778 
Additions and adjustments223 59 282 
Foreign exchange(13)(129)(142)
2021$5,669 $7,249 $12,918 
Goodwill impairment— (216)(216)
Additions and adjustments2,320 — 2,320 
Foreign exchange(54)(88)(142)
2022$7,935 $6,945 $14,880 
Summary of Other Intangible Assets
Weighted Average Amortization Period (Years)Gross
Carrying
Amount
Less
Accumulated
Amortization
Net
Carrying
Amount
Developed technologies
202214$5,440 $2,363 $3,077 
2021135,326 1,956 3,370 
Customer relationships
202215$2,847 $1,322 $1,525 
2021152,324 1,174 1,150 
Patents
202211$343 $297 $46 
202112343 286 57 
Trademarks
202216$425 $220 $205 
202116415 199 216 
In-process research and development
2022N/A$21 $— $21 
2021N/A29 — 29 
Other
20226$105 $94 $11 
20219105 87 18 
Total
202214$9,181 $4,296 $4,885 
2021148,542 3,702 4,840 
Estimated Amortization Expense
20232024202520262027
$620 $588 $568 $510 $490